The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Nanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity
Connor, E. E., Mwamuka, J., Gole, A., Murphy, C. J., & Wyatt, M. D. (2005) · Small · doi:10.1002/smll.200400093 · Cited by 2,406
Gold Nanoparticles for Biology and Medicine
Giljohann, D. A., Seferos, D. S., Daniel, W. L., Massich, M. D., Patel, P. C., & Mirkin, C. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200904359 · Cited by 2,356
Biological applications of gold nanoparticles
Sperling, R. A., Rivera Gil, P., Zhang, F., Zanella, M., & Parak, W. J. (2008) · Chemical Society Reviews · doi:10.1039/b712170a · Cited by 1,799
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,136
Size‐Dependent Endocytosis of Nanoparticles
Zhang, S., Li, J., Lykotrafitis, G., Bao, G., & Suresh, S. (2009) · Advanced Materials · doi:10.1002/adma.200801393 · Cited by 1,059
Gold nanostructures: a class of multifunctional materials for biomedical applications
Cobley, C. M., Chen, J., Cho, E. C., Wang, L. V., & Xia, Y. (2011) · Chem. Soc. Rev. · doi:10.1039/b821763g · Cited by 792
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
The forthcoming applications of gold nanoparticles in drug and gene delivery systems
Pissuwan, D., Niidome, T., & Cortie, M. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.12.006 · Cited by 669
MDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641 · cited 1×
“MDM2 (a master regulator) and its homolog MDMX play an important role in regulating and maintaining the stability or integrity of the p53 pathway [17].”
Paciotti, G. F., Kingston, D. G. I., & Tamarkin, L. (2006) · Drug Development Research · doi:10.1002/ddr.20066 · Cited by 484
Gold nanoparticle platforms as drug and biomacromolecule delivery systems
Duncan, B., Kim, C., & Rotello, V. M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.06.004 · Cited by 469
Cell selective response to gold nanoparticles
Patra, H. K., Banerjee, S., Chaudhuri, U., Lahiri, P., & Dasgupta, A. K. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2007.03.005 · Cited by 456
Water-Soluble, Isolable Gold Clusters Protected by Tiopronin and Coenzyme A Monolayers
Templeton, A. C., Chen, S., Gross, S. M., & Murray, R. W. (1999) · Langmuir · doi:10.1021/la9808420 · Cited by 409
Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., Li, J., Monbo, J., Zella, D., Tarasov, S. G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900947106 · Cited by 391 · cited 2×
“PMI also widely known as p12, is the most known potent inhibitor binding to MDM2 and MDMX complexes resulting in regulated activity and stability of tumor suppressive protein, p53 [15].”
Self-citationTat Peptide as an Efficient Molecule To Translocate Gold Nanoparticles into the Cell Nucleus
de la Fuente, J. M., & Berry, C. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050033+ · Cited by 342
Torchilin, V. P. (2008) · Peptide Science · doi:10.1002/bip.20989 · Cited by 283
Neuropilins in neoplasms: Expression, regulation, and function
Bielenberg, D. R., Pettaway, C. A., Takashima, S., & Klagsbrun, M. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.024 · Cited by 255
Liu, M., Li, C., Pazgier, M., Li, C., Mao, Y., Lv, Y., Gu, B., Wei, G., Yuan, W., Zhan, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008930107 · Cited by 228
Biodistribution of TNF-α-Coated Gold Nanoparticles in An In Vivo Model System
Goel, R., Shah, N., Visaria, R., Paciotti, G. F., & Bischof, J. C. (2009) · Nanomedicine · doi:10.2217/nnm.09.21 · Cited by 186
Size and shape separation of gold nanoparticles with preparative gel electrophoresis
Xu, X., Caswell, K. K., Tucker, E., Kabisatpathy, S., Brodhacker, K. L., & Scrivens, W. A. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.07.056 · Cited by 133
Nanoparticle Targeting at Cells
de la Fuente, J. M., Berry, C. C., Riehle, M. O., & Curtis, A. S. G. (2006) · Langmuir · doi:10.1021/la053029v · Cited by 103
Cyclic RGD Functionalized Gold Nanoparticles for Tumor Targeting
Arosio, D., Manzoni, L., Araldi, E. M. V., & Scolastico, C. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100448r · Cited by 96
Cited by
Huang, K., Ma, H., Liu, J., Huo, S., Kumar, A., Wei, T., Zhang, X., Jin, S., Gan, Y., Wang, P. C., et al. (2012) · ACS Nano · doi:10.1021/nn301282m · Cited by 840
Self-citationMagnetoferritin nanoparticles for targeting and visualizing tumour tissues
Fan, K., Cao, C., Pan, Y., Lu, D., Yang, D., Feng, J., Song, L., Liang, M., & Yan, X. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.90 · Cited by 753
Multifunctional Gold Nanoparticles for Diagnosis and Therapy of Disease
Mieszawska, A. J., Mulder, W. J. M., Fayad, Z. A., & Cormode, D. P. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3005885 · Cited by 724
Current trends and challenges in cancer management and therapy using designer nanomaterials
Navya, P. N., Kaphle, A., Srinivas, S. P., Bhargava, S. K., Rotello, V. M., & Daima, H. K. (2019) · Nano Convergence · doi:10.1186/s40580-019-0193-2 · Cited by 672
Nanomaterials in Targeting Cancer Stem Cells for Cancer Therapy
Qin, W., Huang, G., Chen, Z., & Zhang, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00001 · Cited by 656
Metadata
- Authors
- Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., Wei, T., Cao, W., Zou, G., & Liang, X.-J.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 33
- Issue
- 4
- Pages
- 1180-1189
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2049823839
- Cited by
- 315
- References
- 28
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.